Trinity Biotech plc
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| TRIB | BMRA | CODX | ALBIO.PA | RPID | NCYT.L | |
|---|---|---|---|---|---|---|
| Market cap | 5.23M | 7.98M | 3.19M | 15.48M | 34.18M | 25.58M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -6.2 | 4.4 | -0.4 | 1.8 | -1.0 | -5.1 |
| Price/book | -0.1 | 2.2 | 0.1 | 0.4 | 1.9 | 1.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −77.67% | −34.11% | −96.77% | +56.67% | −75.24% | −10.05% |
| Today | −2.02% | +2.06% | −4.89% | +2.44% | −1.53% | −1.49% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All TRIB news ›Verano (OTCMKTS:VRNOF) & Trinity Biotech (NASDAQ:TRIB) Head-To-Head Survey
Posted by Danessa Lincoln on Nov 2nd, 2026 Trinity Biotech (NASDAQ:TRIB – Get Free Report) and Verano (OTCMKTS:VRNOF – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two…
More from 1 other outlet
Analyzing Trinity Biotech (NASDAQ:TRIB) and Venus Concept (NASDAQ:VERO)
Posted by Sarita Garza on Oct 25th, 2026 Trinity Biotech (NASDAQ:TRIB – Get Free Report) and Venus Concept (NASDAQ:VERO – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the…
Total common shares outstanding of Trinity Biotech Plc Sponsored ADR Class A – GETTEX:TRB0
TradingView Trinity Biotech Plc Sponsored ADR Class A Total common shares outstanding of Trinity Biotech Plc Sponsored ADR Class A
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com2
- tradingview.com2
- defenseworld.net1
- kalkinemedia.com1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.